AtheroNova Investors
AtheroNova develops compounds to safely regress atherosclerotic plaque for the treatment and prevention of cardiovascular diseases
Headquarters:
Irvine, California, United States
Employee Number:
3
Industry:
P4 Medicine
Investor Type:
Healthcare Company
Founded Date:
2006